• Downgrade to Underperform from Hold; cut target price to Rs 620 from Rs 690
• Q4 results were weaker than expected
• Weak guidance for FY25
• New capability additions during the quarter
• H2 recovery hinges on many external factors which are highly unpredictable; Cut our FY25/FY26 EBITDA estimates by 6%/7%
Comments
Post a Comment